Sichuan Hebang Valuation
| 603077 Stock | 2.04 0.01 0.49% |
Based on Macroaxis valuation methodology, the company appears to be overvalued. Sichuan Hebang Biote has a current Real Value of USD1.67 per share. The regular price of the company is USD2.04. Our model measures the value of Sichuan Hebang Biote from inspecting the company fundamentals such as Shares Outstanding of 8.83 B, return on equity of 0.0231, and Operating Margin of 0.02 % as well as reviewing its technical indicators and probability of bankruptcy.
Price Book 0.9601 | Enterprise Value 18.9 B | Enterprise Value Ebitda 30.0604 | Price Sales 1.9575 | Trailing PE 34 |
Overvalued
Today
Please note that Sichuan Hebang's price fluctuation is very risky at this time. Calculation of the real value of Sichuan Hebang Biote is based on 3 months time horizon. Increasing Sichuan Hebang's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Sichuan Hebang is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sichuan Stock. However, Sichuan Hebang's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.04 | Real 1.67 | Hype 2.05 | Naive 1.98 |
The real value of Sichuan Stock, also known as its intrinsic value, is the underlying worth of Sichuan Hebang Biote Company, which is reflected in its stock price. It is based on Sichuan Hebang's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Sichuan Hebang's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Sichuan Hebang Biotechnology helps investors to forecast how Sichuan stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sichuan Hebang more accurately as focusing exclusively on Sichuan Hebang's fundamentals will not take into account other important factors: Sichuan Hebang Cash |
|
Sichuan Hebang Total Value Analysis
Sichuan Hebang Biotechnology is presently estimated to have takeover price of 18.89 B with market capitalization of 18.02 B, debt of 1.17 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Sichuan Hebang fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
18.89 B | 18.02 B | 1.17 B |
Sichuan Hebang Investor Information
About 36.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 0.96. In the past many companies with similar price-to-book ratios have beat the market. Sichuan Hebang Biote last dividend was issued on the 15th of October 2024. The entity had 22:10 split on the 5th of July 2017. Based on the key indicators obtained from Sichuan Hebang's historical financial statements, Sichuan Hebang Biotechnology is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 76.3 M | 80.3 M |
|
| |||||
| Operating Income | 1.1 B | 1.5 B |
|
|
Sichuan Hebang Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Sichuan Hebang has an asset utilization ratio of 35.95 percent. This suggests that the Company is making USD0.36 for each dollar of assets. An increasing asset utilization means that Sichuan Hebang Biotechnology is more efficient with each dollar of assets it utilizes for everyday operations.Sichuan Hebang Ownership Allocation
Sichuan Hebang Biote shows a total of 8.83 Billion outstanding shares. Sichuan Hebang Biote maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Sichuan Hebang Profitability Analysis
The company reported the revenue of 8.82 B. Net Income was 1.28 B with profit before overhead, payroll, taxes, and interest of 5.55 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Sichuan Hebang's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Sichuan Hebang and how it compares across the competition.
About Sichuan Hebang Valuation
The stock valuation mechanism determines Sichuan Hebang's current worth on a weekly basis. Our valuation model uses a comparative analysis of Sichuan Hebang. We calculate exposure to Sichuan Hebang's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sichuan Hebang's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.1 B | 2.2 B |
Sichuan Hebang Quarterly Retained Earnings |
|
Complementary Tools for Sichuan Stock analysis
When running Sichuan Hebang's price analysis, check to measure Sichuan Hebang's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sichuan Hebang is operating at the current time. Most of Sichuan Hebang's value examination focuses on studying past and present price action to predict the probability of Sichuan Hebang's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sichuan Hebang's price. Additionally, you may evaluate how the addition of Sichuan Hebang to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |